封面
市場調查報告書
商品編碼
2075853

糖尿病足潰瘍治療市場:依產品類型、潰瘍類型、最終用戶和地區分類

Diabetic Foot Ulcers Treatment Market, By Product, By Ulcer Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,糖尿病足潰瘍治療市場規模將達到 103.6 億美元,到 2033 年將達到 207 億美元。預計 2026 年至 2033 年的複合年成長率將達到 10.4%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 103.6億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 10.40% 2033年市場規模預測: 207億美元

糖尿病足潰瘍是糖尿病患者常見的併發症,可能導致下肢截肢。依賴胰島素治療糖尿病的患者發生足潰瘍的風險較高。此外,患有糖尿病相關腎臟病、眼科疾病、心臟病和肥胖症的患者風險也較高。飲酒和吸煙也會增加患此病的風險。糖尿病足潰瘍的早期常見症狀包括一隻或雙腳出現異常腫脹、發紅、刺激和異味。糖尿病足潰瘍的治療通常包括控制血糖值、清除壞死組織、傷口敷料包紮和負壓治療。

市場動態

全球糖尿病足潰瘍治療市場的主要企業正致力於採取成長策略,例如推出新產品和獲得監管部門批准,預計這些策略將在預測期內推動市場成長。例如,2019年11月,瑞典生物製藥公司Promore Pharma AB的子公司Pergamum AB獲得了其用於治療糖尿病足潰瘍的候選產品「PXL01」的美國專利。此外,2019年12月,醫療設備公司Orpyx Medical Technologies Inc.推出了用於預防糖尿病足潰瘍和神經病變相關潰瘍的「Orpyx SI Sensory Insoles」。該公司致力於設計和開發用於治療糖尿病足潰瘍的感應鞋墊系統。另外,2017年12月,SANUWAVE Health Inc.的「Dermapace」系統獲得了美國市場批准,用於治療糖尿病足潰瘍。

本研究的主要特點:

  • 該研究揭示了各個細分市場的潛在商機,並為全球糖尿病足潰瘍治療市場說明了一個有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究基於以下參數分析了全球糖尿病足潰瘍治療市場的主要參與者:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球糖尿病足潰瘍治療市場」報告的目標對象包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業利益相關相關人員。
  • 相關人員可以透過利用全球糖尿病足潰瘍治療市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期試飛
  • 流行病學
  • 併購和合作
  • 監管趨勢
  • 主要進展
  • PEST分析

第4章 全球糖尿病足潰瘍治療市場:依產品分類,2021-2033年

  • Advance Wound Dressings
  • 皮膚替代材料
  • 成長要素
  • 傷口護理裝置
  • 其他設備

第5章 全球糖尿病足潰瘍治療市場:依潰瘍類型分類,2021-2033年

  • 神經病變潰瘍
  • 缺血性潰瘍
  • 神經缺血性潰瘍

第6章 全球糖尿病足潰瘍治療市場:依最終用戶分類,2021-2033年

  • 醫院
  • 專科診所
  • 長期照護機構
  • 門診手術中心

第7章 全球糖尿病足潰瘍治療市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 公司簡介
    • 3M Healthcare
    • Braun Melsungen AG
    • Smith & Nephew, Inc.
    • Organogenesis, Inc.
    • Derma Sciences Inc.
    • Sigvaris Inc.
    • Acelity LP Inc.
    • Osiris
    • Molnlycke Health Care AB
    • Alkem Laboratories Ltd.
    • Healthium Medtech
    • Kerecis
    • Podimetrics
    • Carmell Corporation
    • Paracrine, Inc.
    • VIVEX Biologics, Inc.
    • PolarityTE, Inc.

第9章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1357

Diabetic Foot Ulcers Treatment Market is estimated to be valued at USD 10.36 Bn in 2026 and is expected to reach USD 20.70 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 10.36 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.40% 2033 Value Projection: USD 20.70 Bn

Diabetic foot ulcer is a common condition in diabetic patients, which may lead to amputation of the leg. People who rely on insulin for the treatment of diabetes are at high risk of developing a foot ulcer. Moreover, people suffering from diabetes-related kidney, eye, and heart disease and obesity can also suffer from diabetic foot ulcers. The risk of the disease is high in those consuming alcohol and tobacco. The common initial symptoms of diabetic foot ulcer include unusual swelling, redness, irritation, and stenches on one or both feet. Diabetic foot ulcer treatment, usually include control of blood sugar, removal of dead tissue, wound dressings, and negative pressure therapy.

Market Dynamics

Key players operating in the global diabetic foot ulcer treatment market are focusing on adoption of growth strategies such as product launches and regulatory approvals, which are expected to drive the market growth during the forecast period. For instance, in November 2019, Pergamum AB, a subsidiary of Promore Pharma AB, a Sweden-based biopharmaceutical company, received a patent in the U.S. for the pharmaceutical formulation of the product candidate PXL01 used for the treatment of diabetic foot ulcers. Moreover, in December 2019, Orpyx Medical Technologies Inc., a medical device company that designs and develops sensory insole systems for the treatment of diabetic foot ulcers, launched Orpyx SI Sensory Insoles with for the prevention of diabetic foot ulcers and neuropathy-related ulcers. Furthermore, in December 2017, SANUWAVE Health Inc., received the US approval for marketing of the Dermapace system, the indicated to treat diabetic foot ulcer.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for global diabetic foot ulcer treatment market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global diabetic foot ulcer treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include 3M Healthcare, B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, and Molnlycke Health Care AB
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global diabetic foot ulcer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetic foot ulcer treatment market

Detailed Segmentation:

  • Global Diabetic Foot Ulcer Treatment Market, By Product (Revenue, USD Bn, 2021 - 2033)
  • Advance Wound Dressings
  • Skin Substitutes
  • Growth Factors
  • Negative Pressure Wound Therapy Devices
  • Other Devices
  • Global Diabetic Foot Ulcer Treatment Market, By Ulcer Type (Revenue, USD Bn, 2021 - 2033)
  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic Ulcers
  • Global Diabetic Foot Ulcer Treatment Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Long Term Care Centers
  • Ambulatory Surgical Center
  • Global Diabetic Foot Ulcer Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • 3M Healthcare*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
  • Smith & Nephew, Inc.
  • Organogenesis, Inc.
  • Derma Sciences Inc.
  • Sigvaris Inc.
  • Acelity L.P. Inc.
  • Osiris
  • Molnlycke Health Care AB

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Ulcer Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Diabetic Foot Ulcers Treatment Market, By Product, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Advance Wound Dressings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Skin Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Growth Factors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Negative Pressure Wound Therapy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Other Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

5. Global Diabetic Foot Ulcers Treatment Market, By Ulcer Type, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Neuropathic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Neuro-ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

6. Global Diabetic Foot Ulcers Treatment Market, By End User, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Long Term Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

7. Global Diabetic Foot Ulcers Treatment Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021-2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • 3M Healthcare*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Braun Melsungen AG
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Smith & Nephew, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Organogenesis, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Derma Sciences Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Sigvaris Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Acelity L.P. Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Osiris
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Molnlycke Health Care AB
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Alkem Laboratories Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Healthium Medtech
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Kerecis
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Podimetrics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Carmell Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Paracrine, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • VIVEX Biologics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • PolarityTE, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact